source
- Former FDA commissioners slam current HHS leadership over research cuts and regulatory challengesFormer FDA commissioners Rob Califf, Scott Gottlieb and Ned Sharpless publicly criticized the officials running the agency, saying the current HHS leadership is failing the FDA. They highlighted m…
- Verastem reports encouraging early data for KRAS G12D inhibitor in pancreatic cancerVerastem Oncology disclosed early clinical results for its KRAS G12D inhibitor, which is being evaluated in more than 200 patients with advanced solid tumors, including metastatic pancreatic ductal…